showed a trendP =0.034
Overall survival showed a trend toward worse prognosis in patients with germline mutations ( P =0.034); however, this difference did not reach statistical significance in multivariate analysis that included age, 2022 ELN risk classification, and allogeneic HCT status (hazard ratio =1.00; 95% confidence interval: 0.53-1.86; P =0.989) ( Online Supplementary Figure S2 ).